Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893544996> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W2893544996 endingPage "318" @default.
- W2893544996 startingPage "318" @default.
- W2893544996 abstract "Introduction Recently, lack of new antibiotics, together with the rising resistance of antimicrobials against extensively drug-resistant strains of Pseudomonas aeruginosa, Acinetobacter baumannii, and carbapenemase-producing Klebsiella pneumoniae, had caused the restoration of old antibiotics like fosfomycin. Fosfomycin is considered a bactericidal antibiotic of the 1970s. It presents activity against multidrug resistant microorganisms. Patients and methods A randomized, controlled trial was designed between November 2015 and April 2016, including 40 patients diagnosed with ventilator-associated pneumonia (VAP). Patients were classified into two equally sized groups: group A (control group) comprised patients receiving only empirical systemic antibiotics and group B included patients receiving oral fosfomycin combined with empirical systemic antibiotics. Clinical pulmonary infection score (CPIS) and C-reactive protein (CRP) were used as predictors of improvement in both groups. Additionally, improvement and mortality rate were secondary endpoints of assessment. Results Age and sex among both groups did not show significant differences. The majority of patients in groups A and B were diagnosed as early-onset pneumonia 75 and 70%, respectively. K. pneumoniae was the most prevalent organism in cases of early as well as late-onset pneumonia (34.4 and 36%, respectively). CPIS and CRP were improved significantly in group B compared with baseline. Furthermore, CPIS and CRP had been declined significantly in group B compared with group A. Despite the significant improvement of CPIS and CRP in group B, it did not show significant lower mortality than in group A. Conclusion Fosfomycin is an effective antimicrobial agent in the treatment of VAP with low mortality rate. Furthermore, CPIS is a potential score used to evaluate the effectiveness of therapy in cases of VAP." @default.
- W2893544996 created "2018-10-05" @default.
- W2893544996 creator A5009700516 @default.
- W2893544996 creator A5027502004 @default.
- W2893544996 creator A5068067429 @default.
- W2893544996 creator A5072266271 @default.
- W2893544996 date "2018-01-01" @default.
- W2893544996 modified "2023-09-25" @default.
- W2893544996 title "The effect of administration of fosfomycin in the management of ventilator-associated pneumonia" @default.
- W2893544996 doi "https://doi.org/10.4103/ejcdt.ejcdt_25_17" @default.
- W2893544996 hasPublicationYear "2018" @default.
- W2893544996 type Work @default.
- W2893544996 sameAs 2893544996 @default.
- W2893544996 citedByCount "2" @default.
- W2893544996 countsByYear W28935449962021 @default.
- W2893544996 countsByYear W28935449962022 @default.
- W2893544996 crossrefType "journal-article" @default.
- W2893544996 hasAuthorship W2893544996A5009700516 @default.
- W2893544996 hasAuthorship W2893544996A5027502004 @default.
- W2893544996 hasAuthorship W2893544996A5068067429 @default.
- W2893544996 hasAuthorship W2893544996A5072266271 @default.
- W2893544996 hasBestOaLocation W28935449961 @default.
- W2893544996 hasConcept C104317684 @default.
- W2893544996 hasConcept C126322002 @default.
- W2893544996 hasConcept C2776315533 @default.
- W2893544996 hasConcept C2777058267 @default.
- W2893544996 hasConcept C2777184939 @default.
- W2893544996 hasConcept C2777637488 @default.
- W2893544996 hasConcept C2777914695 @default.
- W2893544996 hasConcept C2778897966 @default.
- W2893544996 hasConcept C4937899 @default.
- W2893544996 hasConcept C501593827 @default.
- W2893544996 hasConcept C523546767 @default.
- W2893544996 hasConcept C54355233 @default.
- W2893544996 hasConcept C547475151 @default.
- W2893544996 hasConcept C55493867 @default.
- W2893544996 hasConcept C71924100 @default.
- W2893544996 hasConcept C86803240 @default.
- W2893544996 hasConcept C89423630 @default.
- W2893544996 hasConcept C94665300 @default.
- W2893544996 hasConceptScore W2893544996C104317684 @default.
- W2893544996 hasConceptScore W2893544996C126322002 @default.
- W2893544996 hasConceptScore W2893544996C2776315533 @default.
- W2893544996 hasConceptScore W2893544996C2777058267 @default.
- W2893544996 hasConceptScore W2893544996C2777184939 @default.
- W2893544996 hasConceptScore W2893544996C2777637488 @default.
- W2893544996 hasConceptScore W2893544996C2777914695 @default.
- W2893544996 hasConceptScore W2893544996C2778897966 @default.
- W2893544996 hasConceptScore W2893544996C4937899 @default.
- W2893544996 hasConceptScore W2893544996C501593827 @default.
- W2893544996 hasConceptScore W2893544996C523546767 @default.
- W2893544996 hasConceptScore W2893544996C54355233 @default.
- W2893544996 hasConceptScore W2893544996C547475151 @default.
- W2893544996 hasConceptScore W2893544996C55493867 @default.
- W2893544996 hasConceptScore W2893544996C71924100 @default.
- W2893544996 hasConceptScore W2893544996C86803240 @default.
- W2893544996 hasConceptScore W2893544996C89423630 @default.
- W2893544996 hasConceptScore W2893544996C94665300 @default.
- W2893544996 hasIssue "3" @default.
- W2893544996 hasLocation W28935449961 @default.
- W2893544996 hasOpenAccess W2893544996 @default.
- W2893544996 hasPrimaryLocation W28935449961 @default.
- W2893544996 hasRelatedWork W2124509911 @default.
- W2893544996 hasRelatedWork W2162207945 @default.
- W2893544996 hasRelatedWork W2359370021 @default.
- W2893544996 hasRelatedWork W2796011584 @default.
- W2893544996 hasRelatedWork W2936059048 @default.
- W2893544996 hasRelatedWork W3021121956 @default.
- W2893544996 hasRelatedWork W3164160543 @default.
- W2893544996 hasRelatedWork W4205854213 @default.
- W2893544996 hasRelatedWork W4293105457 @default.
- W2893544996 hasRelatedWork W4309612693 @default.
- W2893544996 hasVolume "67" @default.
- W2893544996 isParatext "false" @default.
- W2893544996 isRetracted "false" @default.
- W2893544996 magId "2893544996" @default.
- W2893544996 workType "article" @default.